FDA PMA FDA Class 3 Approved 🇺🇸 United States

Kit, Dna Detection, Human Papillomavirus

PMA: P080014 · Supplement: S019 · Decision Mar 4, 2014
Classifications
1
FEI Numbers
12
Registration Numbers
12

Basic Information

Device Name
Kit, Dna Detection, Human Papillomavirus
Trade Name
CERVISTA HPV HR TEST
PMA Number
P080014
Supplement Number
S019
Device Class
FDA Class 3
Product Code
MAQ
Generic Name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Medical Specialty
Unknown
Advisory Committee
Microbiology
Decision
Approved
Decision Code
APPR
Decision Date
March 4, 2014
Date Received
August 2, 2013
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR A MANUFACTURING SITE LOCATED AT GEN-PROBE INCORPORATED, SAN DIEGO, CALIFORNIA FOR THE MANUFACTURING OF THE CERVISTA HPV HR AND THE CERVISTA HPV 16/18.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAQ Kit, Dna Detection, Human Papillomavirus